Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sanofi Makes Good On Outsourcing Promise In Deal With Covance

Executive Summary

Sanofi-Aventis, which last year announced plans to transform its R&D model by tapping external sources, announced a multi-layered 10-year partnership with the contract research organization Covance Sept. 30.

You may also be interested in...



Large Chinese CROs To Benefit From Continued Outsourcing Trend, CRO Surveys Say

As Big Pharma continues its restructuring initiatives to outsource services to lower-cost emerging markets, Chinese and U.S. contract research organizations with the largest footprints and broadest capabilities will benefit from the ongoing trend, according to two recently released surveys on the CRO industry

Parexel Says It Is Ideally Positioned As Big Pharma Shakes Up R&D Efforts

Noting its recent five-year contract with Pfizer, the CRO predicts 13% revenue growth for fiscal 2012.

In R&D Shakeup, Pfizer Tries New Outsourcing Model

Contract research organizations Icon and Parexel will become Pfizer's primary clinical trail service providers under the new partnerships.

Related Content

Topics

UsernamePublicRestriction

Register

ID1132956

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel